| Financial Year |
March 31 2023 |
| Monetary Funds |
271,045,521.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,165,812.32 |
| Accounts Receivable |
186,202,726.43 |
| Advances to Suppliers |
641,455.17 |
| Other Receivables |
246,043.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
27,883,017.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,590,060.65 |
| Total Current Assets |
547,107,579.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,782,795.65 |
| Investment Properties |
467,494.39 |
| Fixed Assetes |
371,658,749.34 |
| Under-construction Projects |
75,682,840.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,465,933.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,329,523.55 |
| Deferred Income Tax Assets |
12,202,442.84 |
| Other Non-Current Assets |
28,858,464.00 |
| Sub-Total of Non-Current Assets |
551,744,012.40 |
| Total Assets |
1,098,851,591.78 |
| Short-Term Loans |
71,972,650.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
49,811,241.66 |
| Accounts Received In Advance |
69,708.91 |
| Employee Compensation Payable |
1,756,501.63 |
| Taxes Payable |
16,014,950.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,802,751.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
159,774.93 |
| Other Current Liabilities |
329,007.37 |
| Sub-Total of Current Liabilities |
165,572,224.80 |
| Long-term Loans |
10,013,138.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,017,188.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,168,895.18 |
| Total Liabilities |
185,741,119.98 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
349,126,683.09 |
| Surplus Reserve |
47,615,904.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
315,935,653.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
913,110,471.80 |
| Owner's Equity（Stockholder's Equity） |
913,110,471.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,098,851,591.78 |
